QuantRx Biomedical Corporation
OTC: QTXB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Shalom Z. Hirschman
- Headquarters
- Tualatin, United States
- IPO year
- 2004
- Market cap
- $118.0K
Loading QTXB…
Loading profile data…Frequently asked questions about QTXB
What does QuantRx Biomedical Corporation (QTXB) do?
QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSe...
Where does QTXB trade?
QuantRx Biomedical Corporation (QTXB) trades on the Other OTC.
What sector is QTXB in?
QuantRx Biomedical Corporation (QTXB) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of QuantRx Biomedical Corporation?
Shalom Z. Hirschman is the chief executive officer of QuantRx Biomedical Corporation (QTXB).
Where is QuantRx Biomedical Corporation headquartered?
QuantRx Biomedical Corporation is headquartered in United States.
Does QTXB pay a dividend?
QuantRx Biomedical Corporation (QTXB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QTXB go public?
QuantRx Biomedical Corporation (QTXB) completed its initial public offering in 2004.